| Serial Number | 79301289 |
| Word Mark | NORTHWAY GENE THERAPY CENTER |
| Filing Date | Wednesday, November 18, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 27, 2022 |
| Registration Number | 6854455 |
| Registration Date | Tuesday, September 27, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 14, 2021 |
| Description of Mark | The mark consists of the wording "NORTHWAY GENE THERAPY CENTER," with the "O" in NORTHWAY being represented by the design of a DNA Helix in dark blue and orange, the rest of the wording "NORTHWAY" in dark blue, and the wording "GENE THERAPY CENTER" below in orange. The color white represents background and/or transparent areas and is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19 |
| Indication of Colors claimed | The color(s) dark blue, and orange is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "GENE THERAPY CENTER" |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of pharmaceutical studies; technological consultancy in the field of development of manufacturing processes for biotechnology products |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | UAB "Northway turto valdymas" |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LT |
| Party Name | UAB "Northway turto valdymas" |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LT |
| Party Name | UAB "Northway turto valdymas" |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LT |
| Event Date | Event Description |
| Tuesday, February 7, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, January 13, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, January 13, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 27, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 27, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 27, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 24, 2022 | TTAB RELEASE CASE TO TRADEMARKS |
| Wednesday, August 24, 2022 | OPPOSITION TERMINATED NO. 999999 |
| Wednesday, August 24, 2022 | OPPOSITION DISMISSED NO. 999999 |
| Monday, June 27, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, June 6, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 1, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Sunday, February 6, 2022 | REFUSAL PROCESSED BY IB |
| Thursday, January 20, 2022 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, January 12, 2022 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| Wednesday, January 12, 2022 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| Tuesday, January 11, 2022 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Sunday, December 19, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, December 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 14, 2021 | PUBLISHED FOR OPPOSITION |
| Friday, November 26, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, November 24, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, November 24, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, November 8, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, November 8, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, November 8, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, November 8, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, November 8, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 22, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 22, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 22, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, October 22, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 22, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, October 22, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, October 22, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, October 22, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, October 22, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 16, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, May 30, 2021 | REFUSAL PROCESSED BY IB |
| Thursday, May 13, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, May 13, 2021 | REFUSAL PROCESSED BY MPU |
| Tuesday, May 11, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, May 10, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, April 30, 2021 | ASSIGNED TO EXAMINER |
| Friday, January 8, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, January 4, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 31, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |